NDASUBLINGUALTABLET
Approved
Mar 2009
Lifecycle
Peak
Competitive Pressure
0/100
Clinical Trials
3
Mechanism of Action
short-term treatment of insomnia through binding to the benzodiazepine site of α 1 subunit containing GABA A receptors, increasing the frequency of chloride channel opening resulting in the inhibition of neuronal excitation.
Indications (1)
Clinical Trials (3)
Residual Effects of Zolpidem Tartrate Extended Release and Eszopiclone Vs Placebo
Started Jan 2006
36 enrolled
Insomnia
Zolpidem Tartrate 10 mg Tablets Under Non-Fasting Conditions
Started Mar 2002
24 enrolled
Healthy
Zolpidem Tartrate 10 mg Tablets Under Fasting Conditions
Started Feb 2002
38 enrolled
Healthy
Loss of Exclusivity
LOE Date
Feb 25, 2031
60 months away
Patent Expiry
Feb 25, 2031